When longevity influencer Bryan Johnson publicizes his use of high-dose psychedelics, he creates a risky 'survivorship bias.' His massive audience may only see his curated, successful experience and attempt to replicate it without his resources or preparation, ignoring the unseen negative outcomes others have faced with similar protocols.

Yates engaged deeply with psychedelics like ayahuasca but stopped when he felt he'd learned what he needed. He likens it to a phone call: once the message is delivered, you hang up. He advises against becoming a "psychedelic tourist" who repeatedly seeks the experience for its own sake.

Using substances for transcendental experiences without integrating those states into daily life is a form of escapism. If the experience doesn't change how you show up in your relationships and responsibilities, you are merely treating a symptom, not the cause, which often leads to an increasing dependency on the substance.

Psychedelics disrupt normal brain patterns, which can be powerful for breaking out of neurobiological ruts in middle age. However, using them during the already chaotic and plastic period of brain development in one's 20s may be unnecessarily risky before the brain is 'fully cooked.'

The profound perspective shifts from psychedelics can lead founders to quit their companies, leaving investors high and dry. This has become such a tangible risk that some VCs are now contractually prohibiting founders from using them in their investment deal documents to protect their capital.

To gauge an expert's (human or AI) true depth, go beyond recall-based questions. Pose a complex problem with multiple constraints, like a skeptical audience, high anxiety, and a tight deadline. A genuine expert will synthesize concepts and address all layers of the problem, whereas a novice will give generic advice.

Psychedelics can serve as a high-stakes litmus test for a founder's conviction. An investor might see a founder who hasn't used them as a risk, as a trip could cause a career pivot. Conversely, a founder who continues their B2B SaaS venture post-trip is proven to be a "true believer."

Psychedelics may treat trauma by reducing activity in the brain's outer cortex (responsible for language, planning). This shifts consciousness to deeper regions like the insular cortex, allowing for profound insights and self-compassion without the usual cognitive filters of guilt and blame.

Psychedelics don't erase traumatic memories. Their therapeutic power comes from inducing a massive perspective shift, allowing the individual to view the same event through a completely new and less threatening lens. This insight suggests most psychological suffering is a perspective problem.